Xconomy Boston

Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing

  • Feed Type
  • Date
    3/5/2009
  • Company Name
    Proteon Therapeutics Inc.
  • Mailing Address
    200 West Street Waltham, MA 02451
  • Company Description
    Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
  • Website
    http://www.proteontherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $38,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Undisclosed
  • Venture Investor
    TVM Capital
  • Venture Investor
    Skyline Ventures
  • Venture Investor
    Prism VentureWorks
  • Venture Investor
    Intersouth Partners

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.